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Problem Identification and Description
• Smoking is still the leading preventable 
cause of death in the USA (~438,000 
deaths / year in 2009)1
• ~75% express a desire to quit with only a 
2-3% success rate2
• Financial incentive for smoking cessation 
significantly increases the rates of smoking 
cessation over other interventions.3
2
Vermont has seen a decrease in smoking rates over the past 
decade to under 40 packs per capita in 2016
Public Health and Community Costs
• In Vermont, at an average cost of $8.03 per pack 
and with a per capita consumption of 37.4 packs4
with a population of 624,598 (U.S. Census; 2016), 
the community pays calculated a rate of 
$187,580,520 annually for cigarettes in 2016.
• According to the CDC’s Morbidity and Mortality 
report July 1st, 2005, estimates for average annual 
smoking-attributable productivity losses were 
approximately $61.9 billion for men and $30.5 







1970-2016. Orzechowski and Walker. Tax Burden on Tobacco (Vol. 51).
Community Perspective
Rhonda Williams (802 Quits): 
• As far as smoking is concerned, “[cost] is among the most effective evidence based strategies [to reduce smoking].” 
• ”We find there is quite a bit of substance abuse and mental health that makes it just that much more difficult to quit. 
[Cost] sometimes gets overlooked. It can be up to 40% of discretionary income […] and research to back up tax 
increase has helped to create behavioral change.” 
• “In the data we see that "saving $" is identified as among the top reasons people want to quit”
Dale Stafford, MD:
• “Do you think they realize how much it is effecting their financial situation […] I think that people tend to down-play it 
[…] Its like paying their cable bill or gas mileage. It doesn’t seem to rise to the level of I’m going to make this a 
financial.”




• A double-sided hand-out evaluating 
the financial incentives, rather than 
health benefits, of smoking cessation 
was developed. It was independently 
reviewed by 802Quits with appropriate 
alterations made per their advice.
• The goal of the handout was to 
translate financial losses and 
nicotine replacement therapy (NRT) 
economics in terms of average 
consumer terms (buying power / 
monthly or yearly cost) 
5
Smoking is Expensive!
In 2016 , the average cost of a pack in 
Vermont was $8.03, according to the CDC*.
 How much are you actually spending?
In just 1 month you spend...
And in 1 year...
At 1 PPD you are 
spending the same 
as buying a $14,000 







1970-2016. Orzechowski and Walker. Tax Burden on Tobacco (Vol. 51).Did you know?!
1/2 Pack per 
Day
1 Pack per 
Day
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Alternatives are made Cheaper!
Cigarettes are the Most Expensive** option for Nicotine.
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How much Nicotine can $10 get you? 












To save money, 
Quitting is the 










**Benowitz, N. L., & III, P. J. (1984). Daily intake of nicotine 
during cigarette smoking. Clinical Pharmacology and Th era-
peutics, 35(4), 499–504. doi:10.1038/clpt.1984.67
























The handout was evaluated by both providers at the UVMMC Berlin Family medicine clinic and 
by Rhonda Williams at 802Quits, both of whom believed it would be a new angle to encourage 
smoking cessation in the clinic.
• ”I love it […] It would be great to have a hand out like this because I have been looking for a way to make [cost] 
accessible” – Dale Stafford, MD
• “I really like how you use economic and consumption data […] we might be able to take your template and design per 
our 802Quit brand standards.” – Rhonda Williams, 802Quits
Providers at the clinic expressed interest in using the poster daily with patients that are chronic 
smokers and asked for ways in which they could incorporate it into post-visit summary 
handouts.
Patients interviewed with the poster were shocked by the cumulative costs and were more 
interested in quitting, knowing how much money was being spent.
6
Evaluation of Effectiveness and Limitations
Effectiveness:
It has been recommended that effectiveness be gathered through feedback by a small sample of smokers 
at the hospital or outpatient clinics to see if they have any recommendations. This can be done in a couple 
weeks or months.
If found to be efficacious, 802Quits may be interested in using the template after 802Quits rebranding as a 
tool in the future.
Limitations:
The economics of smoking can be difficult for some patients to appreciate especially on such a small 
medium (2 pages). It is also static: this gives raw figures that do not incorporate each individule patient’s 
history and ask them to calculate. 
A dynamic platform like a website / server application would provide a more personalized figure.
7
Recommendations for Future Interventions
I would highly recommend a calculator in Epic that automatically integrates 
the cost of cigarettes over the years a patient has been smoking to provide 
the most accurate depiction of cost-to-date (CTD) from smoking.
This tool could be programmed using the dataset referenced in this report 
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Informed Consent
Thank you for agreeing to be interviewed. This project is a requirement for the 
Family Medicine clerkship. It will be stored on the Dana Library Scholar Works 
website. Your name will be attached to your interview and you may be cited 
directly or indirectly in subsequent unpublished or published work. The 
interviewer affirms that he/she has explained the nature and purpose of this 
project. The interviewee affirms that he/she has consented to this interview.
Yes __X__ / No _____
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